TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04882527

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive brain stimulation
Description: Stimulation will be applied once per subject with one mA for 20 minutes over either the left inferior frontal lobe, the right inferior frontal lobe or the right superior parietal lobe.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive brain stimulation
Description: Stimulation will be applied once per subject with one mA for 20 minutes over either the left inferior frontal lobe, the right inferior frontal lobe or the right superior parietal lobe.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive brain stimulation
Description: Stimulation will be applied once per subject with one mA for 20 minutes over either the left inferior frontal lobe, the right inferior frontal lobe or the right superior parietal lobe.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive brain stimulation
Description: Stimulation will be applied once per subject with one mA for 20 minutes over either the left inferior frontal lobe, the right inferior frontal lobe or the right superior parietal lobe.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive brain stimulation
Description: Stimulation will be applied once per subject with one mA for 20 minutes over either the left inferior frontal lobe, the right inferior frontal lobe or the right superior parietal lobe.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Non-invasive brain stimulation
Description: Stimulation will be applied once per subject with one mA for 20 minutes over either the left inferior frontal lobe, the right inferior frontal lobe or the right superior parietal lobe.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: The electrode positions and the attachment procedures correspond to those of real tDCS but the electrical current will only be ramped up to 1 mA and switched off completely after 30 s of stimulation.
Study: NCT06287983

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Inspiratory Muscle Trainer (IMT) (POWERbreathe Medic Classic)
Description: Inspiratory muscle training will be started at an intensity of 50% of the patient's measured PIMAX value and will be increased by 2 cm/H20 per day according to patient tolerance, and will be applied for a total of 6 weeks / 5 days per week / 3 sessions per day / 10 breaths per session.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Sample Spondylitis Exercise Program
Description: The Sample Spondylitis Exercise Program recommended by the Spondylitis Association of America will be translated into Turkish and each exercise will be applied in 3\*10 sets. The exercise program will be applied to both groups, 3 sessions a week for 60 minutes for 6 weeks.
Study: NCT04843228

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Bias Modification
Description: There will be four sessions of CBM. Each session will consist of two different part. The first part of the intervention will be the training based on the ambiguous scenario paradigm for perfectionism developed by Dodd (2019). Participants will need to complete word fragments in the last part of the scenario to resolve the ambiguity of the scenario. Then, a comprehension question will be presented to them to underscore the interpretation condition. Feedback will be given after each question. For the second part of the intervention aimed to intervene intolerance to uncertainty, word sentence association paradigm for intolerance to uncertainty developed by Oglesby (2017) will be used. In this intervention, participants will be asked to judge the relatedness of words and sentences which will be presented to them. Feedback will be given after each word-sentence.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Cognitive Bias Modification for Control Group
Description: For the first part of the intervention, the control group will be presented with the same procedures as the active group; however, feedbacks will be given to resolve the scenarios in a neutral way. When it comes to the second part of the intervention, different word-sentence pairings will be presented to the control group.
Study: NCT05539664

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03
Description: The experimental group used the experimental medical device Hydrogen-Oxygen Generator with Nebulizer(Shanghai Asclepius Meditec Co., Ltd. ) The flow rate was 3L/min, and the cumulative treatment time was not less than 6 hours per day.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: the hospital routine oxygen supply equipment (wall oxygen or cylinder oxygen)
Description: the hospital routine oxygen supply equipment (wall oxygen or cylinder oxygen). The flow rate was 3L/min, and the cumulative treatment time was not less than 6 hours per day.
Study: NCT05411731

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional physical therapy treatment
Description: The control group (group A) will receive the exercise program which focused on improving the arm function as well as shoulder abduction and external rotation for 10 week.~stretching Aeroplan positioning
Study: NCT06017869

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MNV-201
Description: Autologous CD34+ cells are isolated from the participant's peripheral blood after mobilization by leukapheresis. Allogeneic mitochondria are isolated under aseptic conditions from healthy donor placenta, cryopreserved and qualified before use.
Study: NCT05975060

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: XBB.1.5 Vaccine (Booster)
Description: Omicron sub variant XBB.1.5 SARS-CoV-2 rS /Matrix-M Adjuvant the monovalent \[5 μg/50 μg\] NVX-CoV2601) XBB.1.5 Vaccine (Booster)

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: XBB.1.5 Vaccine (single dose)
Description: Omicron sub variant XBB.1.5 SARS-CoV-2 rS /Matrix-M Adjuvant the monovalent \[5 μg/50 μg\] NVX-CoV2601) XBB.1.5 Vaccine ( single dose)
Study: NCT05552066

Intervention type: OTHER
Group type: OTHER
Intervention: Standard follow up
Description: Patients enrolled into front phase will be followed in a standard way without any additional procedure except satisfaction questionnaire

Intervention type: OTHER
Group type: OTHER
Intervention: short circuit
Description: Patients included in the post phase will have to complete the cem@santé application. If no contraindications are identified by the plateform with the remote PRO collection, patients will undergo chemotherapy directly the next day (without any medical validation).
Study: NCT06526559

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Barbed suture
Description: Use of two absorbable barbed sutures for each arm in the ureteropelvic anastomosis in minimally invasive dismembered pyeloplasty

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PGA suture
Description: Use of two absorbable polyglactin sutures for each arm in the ureteropelvic anastomosis in minimally invasive dismembered pyeloplasty
Study: NCT06545695

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erlotinib
Description: Part B will be the dose escalation component, in which the subject will initiate 50 mg erlotinib,8 weeks later escalate to 75 mg, and then 8 weeks later to 100 mg erlotinib pending tolerance after each 8-week period.
Study: NCT05727800

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-668
Description: Suspension for oral administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-668
Description: Suspension for oral administration.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Suspension for oral administration.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Suspension for oral administration.
Study: NCT05727514

Intervention type: OTHER
Group type: OTHER
Intervention: music composition
Description: 4-session music composition program for participants lead by a composer-mentor, includes optional viewing of online string quartet performances of final musical scores
Study: NCT05411731

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Constraint induced movement therapy
Description: The study group (group B) who will receive Modified constraint induced movement therapy for 3 hrs. a day 12 hrs. a week in addition to the same exercise program given to the control group for 10 weeks.
Study: NCT06409494

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: EuHZV
Description: Drug(injection)

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: EuHZV
Description: Drug(injection)

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Shingrix
Description: Drug(injection)
Study: NCT04844853

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electroencephalography
Description: 128-channel electroencephalography

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electroencephalography
Description: 128-channel electroencephalography

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electroencephalography
Description: 128-channel electroencephalography

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electroencephalography
Description: 128-channel electroencephalography

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tactile stimulation
Description: Vibrotactile sequence on the forearm

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tactile stimulation
Description: Vibrotactile sequence on the forearm

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tactile stimulation
Description: Vibrotactile sequence on the forearm

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tactile stimulation
Description: Vibrotactile sequence on the forearm

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention Network task (computerized)
Description: Computer-based game challenging orienting and executive attention. The subject must chose which side an animal is going, using left and right buttons, depending on the validity of a cue and the congruency of flankers.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention Network task (computerized)
Description: Computer-based game challenging orienting and executive attention. The subject must chose which side an animal is going, using left and right buttons, depending on the validity of a cue and the congruency of flankers.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Head-toes-knees-schoulders
Description: Following motor commands such as touch your head when they are congruent or incongruent.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Head-toes-knees-schoulders
Description: Following motor commands such as touch your head when they are congruent or incongruent.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Laby 5-12
Description: Test of motor planning using labyrinths

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Laby 5-12
Description: Test of motor planning using labyrinths

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M-ABC 2
Description: Test of motor functions using various subtests of gross and fine motor function.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: M-ABC 2
Description: Test of motor functions using various subtests of gross and fine motor function.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stroop animals
Description: Stroop test for preK children using animals instead of words

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stroop animals
Description: Stroop test for preK children using animals instead of words
Study: NCT04751877

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isatuximab
Description: Isatuximab by IV route, per 28 days cycle - Cycle1: 10 mg/kg on days 1, 8, 15, and 22. Cycles 2 to 12: 10 mg/kg on days 1 and 15. From cycle 13: 10 mg/kg on day 1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isatuximab
Description: Isatuximab by IV route, per 28 days cycle - Cycle1: 10 mg/kg on days 1, 8, 15, and 22. Cycles 2 to 12: 10 mg/kg on days 1 and 15. From cycle 13: 10 mg/kg on day 1.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lenalidomide
Description: Lenalidomide by oral route, per 28 days cycle - 25 mg daily on days 1-21.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide by oral route, per 28 days cycle - 25 mg daily on days 1-21.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: Bortezomib sub-cutaneous, per 28 days cycle - Cycles 1 to 12: 1.3 mg/m2 on days 1, 8, 15. Cycles 13-18: 1.3 mg/m2 on days 1, 15.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Dexamethasone by oral route, per 28 days cycle - 20 mg daily on days 1, 8, 15 and 22.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone by oral route, per 28 days cycle - 20 mg daily on days 1, 8, 15 and 22.
Study: NCT04903795

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hEGFRvIII-CD3 (BRiTE)
Description: Bispecific T cell engager possessing one effector binding arm specific for the epsilon subunit of CD3 (a signaling molecule complex associated with the T cell receptor on T cells) while the opposing target-binding arm is directed against the hEGFRvIII epitope that is differentially expressed on the surface of tumor cells
Study: NCT06432504

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Caffeine content
Description: Participants will drink the same volume of coffee with different amounts of caffeine.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Caffeine content
Description: Participants will drink the same volume of coffee with different amounts of caffeine.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Caffeine content
Description: Participants will drink the same volume of coffee with different amounts of caffeine.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Caffeine content
Description: Participants will drink the same volume of coffee with different amounts of caffeine.
Study: NCT05189028

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: gemcitabine and cisplatin
Description: Neoadjuvant chemotherapy:gemcitabine and cisplatin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine and cisplatin
Description: Neoadjuvant chemotherapy:gemcitabine and cisplatin
Study: NCT06332105

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Glytactin
Description: Glycomacropeptide based protein substitute for dietary treatment of PKU

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: L-AA
Description: Amino acid based protein substitute for dietary treatment of PKU
Study: NCT06474403

Intervention type: PROCEDURE
Group type: OTHER
Intervention: standard Sugarbecker's operation
Description: Eligible candidates who have developed parastomal hernias following stoma creation and consented to the study will undergo laparoscopic TEP repair. The procedure involves an initial unilateral transrectal incision followed by the creation of an preperitoneal or retro-rectus space where a mesh is positioned to reinforce the abdominal wall and the stoma. Also it will has was formed oblique hernia canal. The operative and postoperative outcomes of these patients will be studied in comparison with control group treated with the traditional Sugabecker's operation.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: modified Sugarbecker's operation
Description: Eligible candidates who have developed parastomal hernias following stoma creation and consented to the study will undergo laparoscopic TEP repair. The procedure involves an initial unilateral transrectal incision followed by the creation of an preperitoneal or retro-rectus space where a mesh is positioned to reinforce the abdominal wall and the stoma. Also it will has was formed oblique hernia canal. The operative and postoperative outcomes of these patients will be studied in comparison with control group treated with the traditional Sugabecker's operation.
Study: NCT05848362

Intervention type: OTHER
Group type: OTHER
Intervention: Blood Glucose Measurement Values Taken by Different Methods
Description: In total, blood samples will be collected from 3 different sites (central venous catheter, capillary, arterial catheterization) in the same patient. In total, with 5 different techniques from 3 different regions from the same patient;~ARTERIAL BLOOD SAMPLE i) Washing with 5 cc 1% Heparin fluid ii) Washing with 10 cc 1% Heparin fluid CAPILAR BLOOD SAMPLE iii) Right / Left Fingertip iv) Thumb base CENTRAL VENOUS CATHETERIZATION BLOOD SAMPLE will be collected.
Study: NCT05098847

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Sintilimab plus lenvatinib will be initiated on day 14 after cryoablation. Sintilimab will be administered at 200 mg i.v. every 3 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Sintilimab plus lenvatinib will be initiated on day 14 after cryoablation. Lenvatinib (bodyweight ≥ 60 kg, 12 mg; \< 60 kg, 8 mg) was given orally daily every 3 weeks until documented disease progression, development of unacceptable toxicity, participant request, or withdrawal of consent.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cryoablation
Description: Cryoablation treatment starts at day 0. Cryoablation will be performed with a two-cycle freeze-thaw phase protocol; US or non-contrast CT images will be obtained to visualize the evolving ablation zone
Study: NCT05713565

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: A digital care solution for patients with Coronary Artery Disease
Description: A digital care solution that provides remote patient monitoring and a patient support program specifically developed for CAD patients. The digital care solution empowers self-assessment of CAD symptoms as well as positive lifestyle change by gamification, altruistic rewards, and engaging content with relevant tasks or missions to be completed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of care for patients with Coronary Artery Disease
Description: Follow-up and continuous care as usual in outpatient care (i.e., Standard of Care). The participants in the Standard of Care - control group will also receive an information leaflet about relevant lifestyle modifications for CAD.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care for patients with Coronary Artery Disease
Description: Follow-up and continuous care as usual in outpatient care (i.e., Standard of Care). The participants in the Standard of Care - control group will also receive an information leaflet about relevant lifestyle modifications for CAD.
Study: NCT04880148

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Thyme and Honey-based oral spray
Description: 4 X Sprays in the oral cavity before, immediately after and 6 hours following the radiotherapy session

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral spray
Description: 4 X Sprays in the oral cavity before, immediately after and 6 hours following the radiotherapy session
Study: NCT06287983

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The Sample Spondylitis Exercise Program
Description: The Sample Spondylitis Exercise Program recommended by the Spondylitis Association of America will be translated into Turkish and each exercise will be applied in 3\*10 sets. The exercise program will be applied to both groups, 3 sessions a week for 60 minutes for 6 weeks.
Study: NCT05805787

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupressure
Description: Acupressure will be applied to the elderly in the experimental group once a day, 5 days a week (Monday-Friday) for a week. The application will last for 2 weeks. A total of 10 sessions of acupressure will be applied. Acupressure application will be applied by researchers who have been trained and certified on this subject. While the elderly are in supine position, pressure will be applied to each acupressure point, respectively, Tianshu (ST25), Guanyuan (CV4) and Hegu (LI4) for 2 minutes for a total of 6 minutes.
Study: NCT06047353

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy
Description: Motivational Enhancement Therapy (MET) is based on the principles of motivational interviewing and is designed to promote self-efficacy and maximize behavioral change. MET will be given via phone and/or in person (approximately 30 minutes) at baseline, week 1, week 2, week 4, and week 8.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Positive Airway Pressure (PAP) therapy
Description: Positive Airway Pressure (PAP) therapy will be administered as per standard of care.
Study: NCT04854382

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tailored information
Description: Tailored information about coronavirus for patients with chronic kidney disease by information videos followed by a teach back procedure
Study: NCT05316506

Intervention type: OTHER
Group type: OTHER
Intervention: Anticipated Discomfort Language
Description: This language involves pain descriptors provided from physician to patient during procedure.

Intervention type: OTHER
Group type: OTHER
Intervention: Objective Descriptive Language
Description: This language involves neutral/objective descriptors provided from physician to patients during procedure.
Study: NCT05469451

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Low level laser therapy
Description: Irradiated with a low power density laser of 940 (nm), 100 megawatt, which will be calibrated and the result of the calibration will be checked with the use of the power meter. The equipment used will be a diode laser (BIOLASE™), the area to be irradiated will be the anterior segment of the lower arch, each tooth will be irradiated for a time of 10 seconds on the vestibular surfaces of the teeth and 10 seconds on the lingual surfaces of the teeth, both at gingival level and at apical level in scanning mode.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Low level laser therapy
Description: Irradiated with a low power density laser of 940 (nm), 100 megawatt, which will be calibrated and the result of the calibration will be checked with the use of the power meter. The equipment used will be a diode laser (BIOLASE™), the area to be irradiated will be the anterior segment of the lower arch, each tooth will be irradiated for a time of 10 seconds on the vestibular surfaces of the teeth and 10 seconds on the lingual surfaces of the teeth, both at gingival level and at apical level in scanning mode.
Study: NCT05630326

Intervention type: OTHER
Intervention: comparing, prevalence
Description: Comparing infants with UTIs caused by ESBL organism, or non ESBL organism.

Intervention type: OTHER
Intervention: assessment
Description: comparing infants with UTIs caused by ESBL organism, or non ESBL organism.